commercialization

Explore the latest in nucleic acid amplification.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

A challenge to the first CRISPR patent just got teeth.

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.

Researchers determine why larval oysters and mussels are sensitive to reduced pH.

Researchers stake their proprietary claim on the genome-editing technique.

Is the push for science to save the still flailing economy a threat to scientific research?

Despite the down economy, universities are ramping up their efforts to commercialize their research.